To analyze hyperreflective foci typically seen in diabetic macular edema (DME) in
optical coherence tomography (OCT).
Prospective clinical trial.
Twelve consecutive patients with treatment-naïve, clinically significant DME.
During a same-day examination, a standardized visual acuity assessment (Early Treatment
of Diabetic Retinopathy Study protocol), infrared fundus imaging, color fundus photography,
and biomicroscopy were performed. Additionally, all patients were scanned using Stratus,
Cirrus, and Spectralis OCT and results correlated.
Morphologic changes secondary to DME.
In all eyes with DME, distinct hyperreflective foci distributed throughout all retinal
layers were found in the OCT scans of all 3 OCT devices. These deposits could not
be identified by infrared imaging, fundus photography, or biomicroscopy as long as
they were not confluent. Accumulations of such foci at the border of the outer nuclear
and in the outer plexiform layer were recognizable clinically as hard exudates showing
the same hyperreflective features in OCT. The hyperreflectivity of these foci did
not correspond with intraretinal hemorrhage, nor did the lesions cause the characteristic
OCT laser beam scattering phenomena typically seen secondary to intraretinal bleedings
or microaneurysms. Further, they were detected within the walls of intraretinal microaneurysms.
Well-demarcated, hyperreflective foci were identified in the retina of patients with
DME. The deposits were located within walls of intraretinal microaneurysms and scattered
throughout all retinal layers, forming confluent plaques in the outer plexiform layer.
It is suggested that the foci represent extravasated lipoproteins and/or proteins
being a very early subclinical barrier breakdown sign in DME.